1-4 of 4
Kate Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Development of EDIT301, an Autologous Cell Therapy Comprising AsCas12a-RNP Modified Mobilized Peripheral Blood-CD34 + Cells for the Potential Treatment of Transfusion Dependent Beta Thalassemia

Patricia Sousa, Tusneem Janoudi, Edouard deDreuzy, Mark S Shearman, Kate Zhang, Kai-Hsin Chang
Journal: Blood
Blood (2021) 138 (Supplement 1): 1858.
https://doi.org/10.1182/blood-2021-149956
Published: 2021
Journal Articles

A Bicistronic Vector Expressing CD16 and a Membrane Bound IL-15 Construct in iPSC Derived NK Cells Increased Cytotoxicity and Persistence

Alexander G Allen, Rithu Pattali, Kaitlyn M Izzo, Jared A Getgano, Kevin M Wasko, Laura C Blaha, John A Zuris, Kate Zhang, Mark S Shearman, Kai-Hsin Chang
Journal: Blood
Blood (2021) 138 (Supplement 1): 4809.
https://doi.org/10.1182/blood-2021-153258
Published: 2021
Journal Articles

Deletion of CISH and TGFβR2 in iPSC-Derived NK Cells Promotes High Cytotoxicity and Enhances In Vivo Tumor Killing

Alexandra Gerew, Steven Sexton, Kevin M Wasko, Mark S Shearman, Kate Zhang, Kai-Hsin Chang, Samia Q. Khan
Journal: Blood
Blood (2021) 138 (Supplement 1): 2780.
https://doi.org/10.1182/blood-2021-150731
Published: 2021
Journal Articles

Robust Pre-Clinical Results and Large-Scale Manufacturing Process for Edit-301: An Autologous Cell Therapy for the Potential Treatment of SCD

Edouard De Dreuzy, PhD, Jack Heath, Patricia Sousa, Tusneem Janoudi, Harry An, PhD, Scott Hansen, David K. Wood, PhD, Charles F Albright, PhD, Sandra Teixeira, PhD, Tamara Monesmith, Kate Zhang, PhD, Kai-Hsin Chang, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-140073
Published: 2020